Elevance Health, Inc.
ELVHealthcareNASDAQHealthcare Plans
Scan Results
Daily timeframeElevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. With a market capitalization of $85.01B, it sits in large-cap territory. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Market Cap
$85.01B
Beta
0.67
P/E (TTM)
16.58
P/E (Fwd)
13.38
EPS (TTM)
$23.61
EPS (Fwd)
$29.25
ROE
12.1%
ROA
4.0%
Cash
$37.07B
Total Debt
$31.84B
Free CF
$4.30B
52W Change
2.9%
Annual Financials
Cash vs Debt
Elevance Health, Inc. holds $37.07B in cash against $31.84B in total debt, giving it a net cash position. This means the company could theoretically pay off all its debt and still have cash remaining. Annual free cash flow of $4.30B supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. ROE of 12.1% points to decent capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. ROA of 4.0% is on the lower side, which is common in asset-heavy industries. Revenue has grown from $156.59B (2022) to $199.12B (2025), reflecting a 27% increase over the period.
The relatively low beta of 0.67 suggests ELV is a less volatile holding compared to the broader index. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing ELV.